83-5978-03 Amyloid Beta, Lecanemab Biosimilar 1mg 047626
特徴
- Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis.
- Interaction between APP molecules on neighboring cells promotes synaptogenesis.
- Involved in cell mobility and transcription regulation through protein-protein interactions.
- Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb.
- Couples to apoptosis- inducing pathways such as those mediated by G(o) and JIP.
- Inhibits G(o) alpha ATPase activity (By similarity).
- Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity).
- By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons.
- Involved in copper homeostasis/oxidative stress through copper ion reduction.
- In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation.
- Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV.
- The splice isoforms that contain the BPTI domain possess protease inhibitor activity.
- Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons.
- Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1.
- N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6).
- Applications:Suitable for use in ELISA, Neutralization, Functional Assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Lecanemab.
- Other applications not tested.
- Recommended Dilution:Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4℃ for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20℃.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:1mg
- 抗体種類:Mab
- 宿主:human
- Source Antibody:human
- Grade:Highly Purified
- Purity:≥95% (reducing SDS-PAGE, HPLC). Endotoxin: ≤1EU/mg (LAL)
- Form:Supplied as a 0.2uM filtered solution, pH 7.4. No stabilizers or preservatives added.
- Specificity:Recognizes human Amyloid Beta.
- Isotype:IgG1
- Calc Applications Abbrev:E N
- Calc Crossreactivity:Hu
- Immunogen:Recombinant protein corresponding to human Amyloid Beta (lecanemab), expressed in mammalian cells.
- Swiss Prot Number:P05067
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
83-5978-02
Amyloid Beta, Lecanemab Biosimilar 100ug
|
|
|
83-5978-04
Amyloid Beta, Lecanemab Biosimilar 5mg
|
|
|
83-5978-03
Amyloid Beta, Lecanemab Biosimilar 1mg
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





